Funded Tech Companies
Cequent Pharmaceuticals
Based in Cambridge, Cequent Pharmaceuticals was bought by Marina Biotech.
Company Overview
Company Name
Cequent Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Kendall Sq. Building 700 First Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Cequent Pharmaceuticals, Inc. is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of products to treat gastrointestinal diseases, including familial polyposis, inflammatory bowel disease and colon cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/1/2010
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Parker
Chief Financial Officer
Lisa Velardo
VP - Bus. Development
Susie Truong
VP - R & D
Johannes Fruehauf
VP - Regulatory Affairs
Pamela Fekete
Company Investors
- Novartis Venture Fund (Lauren Silverman)
- New England Partners (Thomas Hancock)
- Pappas Ventures (Eric Linsley)
- Amidzad Partners (Chiang Li)
- Novartis BioVenture Fund (Steven Tregay)
- Nexus Medical Partners
- Amidzad Partners (Herbert Hooper)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs